GVR Report cover Carpal Tunnel Release Systems Market (2026 – 2035)Report

Carpal Tunnel Release Systems Market (2026 – 2035)

Size, Share & Trends Analysis Report By Product (Open Carpal Tunnel Release Systems, Endoscopic Carpal Tunnel Release Systems), By End Use (Hospitals, Ambulatory Surgical Centers, Specialty Clinics), By Region, And Segment Forecasts

Market Size, 2025

$724.0M

Market Estimate, 2026

$770.3M

Market Forecast, 2035

$1,346.3M

CAGR, 2026–2035

6.4%

Carpal Tunnel Release Systems Market Summary

The global carpal tunnel release systems market size was valued at USD 724.0 million in 2025 and is projected to grow from USD 770.3 million in 2026 to USD 1,346.3 million in 2035, at a CAGR of 6.4% from 2026 to 2035. North America dominated the market, accounting for the largest revenue share in 2025. The global market is witnessing steady growth, driven by the increasing burden of carpal tunnel syndrome (CTS), growing preference for minimally invasive surgical procedures, and rising adoption of advanced endoscopic and ultrasound-guided carpal tunnel release techniques.

Key Market Trends & Insights

  • By product: The endoscopic carpal tunnel release systems segment held the largest market share in 2025.
  • By end use: The hospitals segment held the largest market share in 2025.

Regional Highlights

  • Largest regional market: North America (2025)
  • Fastest-growing regional market: Asia Pacific (highest CAGR, 2026-2035)

Market Size & Forecast

  • Market size in 2025: USD 724.0 Million
  • Estimated market size in 2026: USD 770.3 Million
  • Projected market size by 2035: USD 1,346.3 Million
  • CAGR (2026-2035): 6.4%
Ask a question about the carpal tunnel release systems market
Try asking
✓Every figure cited from GVR research Prefer the report? Download free sample →


The market for carpal tunnel release systems is experiencing steady growth as the number of people diagnosed with carpal tunnel syndrome continues to increase worldwide. The expanding geriatric population, increasing demand for effective treatment of carpal tunnel syndrome, and ongoing technological advancements in hand surgery are further supporting market growth. The growing adoption of endoscopic release procedures, particularly in outpatient settings, is also contributing to demand for advanced carpal tunnel release systems.

Carpal tunnel release systems market size and growth forecast (2025-2035)Source: Grand View Research, IR Documents, Primary Interviews, Paid Databases

To learn more about this report, icon Download Free Sample Report

Rising cases associated with repetitive hand movements, prolonged computer use, diabetes, obesity, and an aging population are driving the demand for effective surgical treatment. Healthcare providers are increasingly adopting minimally invasive and ultrasound-guided release systems because they offer smaller incisions, faster recovery, reduced post-operative pain, and shorter hospital stays. Continuous improvements in surgical instruments and imaging technologies are also helping surgeons achieve greater precision and ensure better patient outcomes.

Despite the positive outlook, the market faces several challenges. Advanced carpal tunnel release systems often involve higher procedural and equipment costs, limiting their adoption in cost-sensitive healthcare settings. In addition, a lack of trained surgeons experienced in minimally invasive and ultrasound-guided procedures, particularly in developing countries, can slow the adoption of newer technologies. Many patients also continue to rely on conservative treatments such as splinting, physical therapy, and corticosteroid injections before considering surgical intervention.

The market presents significant opportunities as healthcare systems increasingly prioritize outpatient and minimally invasive procedures. The rapid expansion of ambulatory surgical centers, growing awareness of early diagnosis, and wider availability of image-guided surgical techniques are expected to support future demand. Furthermore, ongoing innovations in ultrasound-guided devices, disposable surgical instruments, and precision hand surgery technologies are improving procedural safety and efficiency. As patients seek faster recovery and healthcare providers focus on improving surgical outcomes, the adoption of advanced carpal tunnel release systems is expected to accelerate over the coming years.

Analyst Perspective

The carpal tunnel release systems industry is projected to grow as healthcare providers increasingly adopt minimally invasive surgical techniques offering smaller incisions, faster recovery, and greater procedural efficiency. Technological advancements in endoscopic and ultrasound-guided release systems are supporting improved visualization, surgical precision, and expansion of carpal tunnel release procedures into outpatient and ambulatory settings. Growing awareness of CTS, with increasing volume of outpatient hand surgeries, is further supporting market expansion. However, high equipment costs and required specialized surgical training remain key challenges in smaller healthcare facilities and emerging markets. Nevertheless, continued innovation, expansion of ASCs, and increasing adoption of advanced minimally invasive technologies are expected to create growth opportunities.

Product Insights

The endoscopic carpal tunnel release systems segment held the largest market share in 2025. The segment's leadership is attributed to the growing preference for minimally invasive procedures that offer smaller incisions, reduced post-operative pain, faster recovery, and quicker return to daily activities. Endoscopic systems also provide enhanced visualization of the transverse carpal ligament, enabling surgeons to perform precise and efficient procedures while minimizing tissue damage. Increasing adoption by hospitals and ambulatory surgical centers, along with continuous technological advancements in endoscopic instruments, is further supporting the segment's dominance.

The ultrasound-guided carpal tunnel release systems segment is expected to register the fastest CAGR over the forecast period. The increasing use of real-time ultrasound imaging allows surgeons to perform highly accurate, minimally invasive procedures through very small incisions while reducing the risk of complications. Growing clinical evidence supporting ultrasound-guided techniques, combined with rising demand for office-based procedures and faster patient recovery, is accelerating market adoption. Furthermore, ongoing product innovations and expanding surgeon training programs are expected to increase the use of ultrasound-guided carpal tunnel release systems across both developed and emerging healthcare markets.

For instance, in October 2025, Sonex Health, Inc. announced that it achieved an enrollment target of over 1,300 patients in the landmark MISSION registry, the largest multi-arm U.S. clinical study evaluating ultrasound-guided carpal tunnel release (UGCTR) using its UltraGuideCTR system. The study is generating real-world evidence to support the safety, effectiveness, and broader adoption of ultrasound-guided carpal tunnel release procedures.

End Use Insights

The hospitals segment held the largest market share in 2025. The segment's dominance is attributed to the high volume of carpal tunnel release procedures performed in hospitals, supported by advanced surgical infrastructure, specialized orthopedic and hand surgeons, and access to comprehensive diagnostic and imaging technologies. Hospitals are often the preferred treatment setting for patients with complex cases, multiple comorbidities, or those requiring specialized perioperative care. In addition, the availability of advanced endoscopic and ultrasound-guided surgical systems, favorable reimbursement policies, and multidisciplinary treatment approaches has strengthened the adoption of innovative carpal tunnel release technologies in hospital settings. Continuous investments in minimally invasive surgical capabilities and patient safety initiatives further support the segment's leadership.

The ambulatory surgical centers (ASCs) segment is expected to register the fastest CAGR over the forecast period. The increasing preference for minimally invasive procedures, coupled with the growing shift toward outpatient surgical care, is driving demand for carpal tunnel release procedures in ASCs. These facilities provide cost-effective treatment, shorter procedure times, faster patient discharge, and lower overall healthcare costs compared to traditional hospital settings. Advances in endoscopic and ultrasound-guided release systems have enabled surgeons to safely perform procedures under local anesthesia in outpatient environments, improving patient convenience and recovery. In addition, the expansion of ambulatory surgery networks, favorable reimbursement for same-day procedures, and increasing patient preference for efficient, minimally invasive care is expected to further accelerate the adoption of carpal tunnel release systems in ASCs.

The increasing number of outpatient carpal tunnel release procedures and the growing adoption of ultrasound-guided minimally invasive techniques in ASCs are accelerating the demand for advanced carpal tunnel release systems. For instance, in June 2026, Sonex Health announced the publication of the largest multicenter study comparing ultrasound-guided carpal tunnel release (CTR-US) with traditional open carpal tunnel release. The study demonstrated improved patient outcomes, including smaller incisions, faster wound healing, reduced opioid use, and higher patient satisfaction, reinforcing the growing adoption of minimally invasive procedures in ambulatory surgical centers.

Regional Insights

North America Carpal Tunnel Release Systems Market Trends

The North America carpal tunnel release systems industry held the largest global market share in 2025. The region's dominance is driven by the high prevalence of carpal tunnel syndrome, well-established healthcare infrastructure, and widespread adoption of minimally invasive surgical techniques. The presence of leading medical device manufacturers, favorable reimbursement policies, and increasing awareness of early diagnosis and treatment have further supported market growth. In addition, the growing number of outpatient hand surgeries and the rapid adoption of endoscopic and ultrasound-guided carpal tunnel release systems continue to strengthen North America's leading position in the market.

Asia Pacific Carpal Tunnel Release Systems Market

The Asia Pacific carpal tunnel release systems industry is expected to register the fastest growth over the forecast period on account of rising healthcare expenditure and improving access to specialized orthopedic care. Moreover, the expansion of ambulatory surgical centers is driving demand for advanced carpal tunnel release systems across the region. Increasing cases of repetitive strain injuries associated with industrialization and office-based occupations, along with growing investments in healthcare infrastructure, are further supporting market expansion. The adoption of minimally invasive surgical procedures and advanced imaging technologies is expected to accelerate the use of carpal tunnel release systems in countries such as China, Japan, South Korea, and India.

The growing focus on expanding access to minimally invasive hand surgery technologies across Asia Pacific is encouraging manufacturers and healthcare providers to strengthen their regional presence through strategic collaborations and product commercialization. For instance, in March 2024, Indian orthopedic surgeon Dr. Banarji B. H. was granted a patent for an arthroscopic carpal tunnel release device designed to perform minimally invasive decompression through a small incision. The innovation is expected to support the adoption of advanced carpal tunnel release procedures across Asia Pacific by improving surgical efficiency and reducing patient recovery time.

Key Carpal Tunnel Release Systems Company Insights

This market consists of global and regional manufacturers of medical devices that compete through innovation of products and technology, partnership strategies, and clinical studies. The top companies in this market are spending on minimally invasive surgery technology, ultrasonographically guided release system, and other hand surgery systems to enhance their market share and cater to increasing demands for improved carpal tunnel release procedures.

Key Carpal Tunnel Release Systems Companies

The following key companies have been profiled for this study on the carpal tunnel release systems market:

  • Sonex Health, Inc.

  • Arthrex, Inc.

  • CONMED Corporation

  • Integra LifeSciences Corporation.

  • MicroAire

  • Trice Medical

  • A.M. Surgical

  • Innomed, Inc.

  • Stryker

Recent Developments

  • In March 2026, Sonex Health, Inc. announced publication of the first real-world comparison of ultrasound-guided carpal tunnel release using UltraGuideCTR and endoscopic carpal tunnel release based on MISSION Registry data. The findings highlighted clinical advantages of ultrasound-guided release, supporting broader adoption of minimally invasive treatment.
  • In August 2025, Arthrex, Inc. received a Bronze Edison Award for its NanoScopic Release System, an innovative endoscopic solution for carpal tunnel surgery. The system combines the NanoNeedle Scope with the Centerline Carpal Tunnel Release device to enable minimally invasive, office-based procedures under local anesthesia, improving surgical efficiency and patient recovery.

Carpal Tunnel Release Systems Market Report Scope

Report Attribute

Details

Market size in 2025

USD 724.0 million

Estimated market size in 2026

USD 770.3 million

Projected market size by 2035

USD 1,346.3 million

Growth rate

CAGR of 6.4% from 2026 to 2035

Base year for estimation

2025

Actual data

2021 – 2024

Forecast period

2026 – 2035

Quantitative units

Revenue in USD million and CAGR from 2026 to 2035

Report coverage

Revenue forecast, company ranking, competitive landscape, growth factors, and trends

Segments covered

Product, end use, and region

Regional Scope

North America; Europe; Asia Pacific; Latin America; Middle East & Africa

Country Scope

U.S.; Canada; Mexico; UK; Germany; France; Italy; Spain; China; Japan; India; Australia; South Korea; Brazil; Argentina; South Africa; Saudi Arabia; UAE

Key companies profiled

Sonex Health, Inc.; Arthrex, Inc.; CONMED Corporation; Integra LifeSciences Corporation; MicroAire; Trice Medical; A.M. Surgical; Innomed, Inc.; Stryker

Customization scope

Free report customization (equivalent to 8 analyst working days) with purchase. Addition or alteration to country, regional & segment scope.

Pricing and purchase options

Avail of customized purchase options to meet your exact research needs. Explore purchase options

Carpal Tunnel Release Systems Market Report Segmentation

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends and opportunities across each sub-segment from 2021 to 2035. For this study, Grand View Research has segmented the global carpal tunnel release systems market report based on product, end use, and region:

  • Product Outlook (Revenue, USD Million, 2021 - 2035)

    • Open Carpal Tunnel Release Systems

    • Endoscopic Carpal Tunnel Release Systems

    • Ultrasound-Guided Carpal Tunnel Release Systems

    • Mini-Invasive Kit-Based Carpal Tunnel Release Systems

  • End Use Outlook (Revenue, USD Million, 2021 - 2035)

    • Hospitals

    • Ambulatory Surgical Centers

    • Specialty Clinics

    • Others

  • Regional Outlook (Revenue, USD Million, 2021 - 2035)

    • North America

      • U.S.

      • Canada

      • Mexico

    • Europe

      • UK

      • Germany

      • France

      • Italy

      • Spain

    • Asia Pacific

      • China

      • Japan

      • India

      • Australia

      • South Korea

    • Latin America

      • Brazil

      • Argentina

    • Middle East and Africa (MEA)

      • South Africa

      • Saudi Arabia

      • UAE

Frequently Asked Questions About This Report

About the Author(s)

Medical Devices Research Team

Healthcare · Medical Devices

This report was authored by the medical devices research team at Grand View Research - comprising two research analysts, one senior research analyst, and one industry expert - with specialized expertise in the medical devices segment of the healthcare industry. All findings are based on proprietary healthcare databases, executive interviews, and regulatory analysis, subject to internal peer review prior to publication.

Last Updated:

Speak to Analyst

Trusted market insights - try a free sample

See how our reports are structured and why industry leaders rely on Grand View Research. Get a free sample or ask us to tailor this report to your needs.

logo
GDPR & CCPA Compliant
logo
ISO 9001 Certified
logo
ISO 27001 Certified
logo
ESOMAR Member
Grand View Research is trusted by industry leaders worldwide
client logo
client logo
client logo
client logo
client logo
client logo